Table 2.
MNL | Scale-adjusted latent class | |||||||
---|---|---|---|---|---|---|---|---|
Parameters | Class-1 (54%) | Class-2 (34%) | Class-3 (12%) | |||||
coef. | s.e. | coef | s.e. | coef | s.e. | coef | s.e. | |
ASC | −1.270* | 0.076 | −1.172* | 0.133 | −2.146* | 0.208 | 0.549** | 0.247 |
Cost | −0.031* | 0.002 | −0.036* | 0.003 | −0.036* | 0.003 | −0.036* | 0.003 |
Target people: | ||||||||
People with disability | 0.590* | 0.065 | 0.832* | 0.146 | 0.086 | 0.084 | 0.479** | 0.225 |
People with drug addiction | −1.570* | 0.083 | −2.232* | 0.231 | −0.442* | 0.135 | −1.775** | 0.715 |
People with cancer | 1.560* | 0.119 | 2.017* | 0.277 | 0.645* | 0.171 | 1.706* | 0.371 |
People with mental health problems | 0.310* | 1.728 | 0.677* | 0.154 | −0.070 | 0.134 | −0.622** | 0.271 |
People with obesity | −1.150* | 0.078 | −1.583* | 0.161 | −0.450* | 0.107 | 0.094 | 0.276 |
People with asthma | 0.260* | 0.085 | 0.289** | 0.120 | 0.231*** | 0.138 | 0.118 | 0.256 |
Target age: | ||||||||
Young (less than 18) | 0.090** | 0.040 | 0.175* | 0.054 | 0.036 | 0.046 | −0.422** | 0.212 |
Adults (18–65) | 0.180* | 0.041 | 0.274* | 0.068 | 0.071 | 0.051 | −0.175 | 0.166 |
Elderly (more than 65) | −0.270* | 4.300 | −0.449* | 0.074 | −0.107** | 0.052 | 0.597* | 0.163 |
Implementation time: | ||||||||
Between 6–12 months | −0.027 | 0.038 | 0.027 | 0.046 | −0.075*** | 0.042 | 0.164 | 0.132 |
More than 12 months | −0.029 | 0.038 | −0.036 | 0.046 | 0.015 | 0.040 | −0.254 | 0.163 |
Between 0–5 months | 0.056 | 1.604 | 0.009 | 0.045 | 0.060 | 0.044 | 0.090 | 0.123 |
Whether it works: | ||||||||
It works but not scientifically proven | −0.250* | 0.041 | −0.201* | 0.060 | −0.194* | 0.052 | −0.417** | 0.164 |
It works and scientific studies confirm this | 0.210 | 5.612 | 0.175* | 0.046 | 0.113** | 0.045 | 0.295** | 0.125 |
Experts say it works elsewhere in the NHS | 0.040 | 0.039 | 0.026 | 0.051 | 0.081*** | 0.044 | 0.122 | 0.131 |
Potential health benefits: | ||||||||
Moderate health (50%) | −0.360 | −8.731 | −0.283* | 0.060 | −0.261* | 0.056 | 0.015 | 0.130 |
Good health (75%) | 0.110* | 0.037 | 0.061 | 0.041 | 0.072** | 0.037 | −0.011 | 0.122 |
Best health (100%) | 0.250* | 0.038 | 0.222* | 0.061 | 0.189* | 0.050 | −0.004 | 0.121 |
Scale | λ1 = 1, λ2 = 2.65 (s.e. = 0.375) | |||||||
Probabilities | ||||||||
Class size | 0.541* | 0.040 | 0.338 | 0.037* | 0.121* | 0.026 | ||
Scale λ1 | 0.652* (s.e. = 0.086) | |||||||
Log-likelihood | −2704.018 | −2383.155 | ||||||
Pseudo R-squared | 0.20 | 0.39 | ||||||
Number of parameters | 15 | 47 | ||||||
Number of observation | 3000 | 3000 |
Variables effects-coded. For clarity, we also present the baseline levels, which are arbitrarily chosen. *significant at p < 0.01; **significant at p < 0.05, ***significant at p < 0.10.